Related Experiment Video
Updated: Dec 24, 2025

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
miRNA-186 Improves Sepsis Induced Renal Injury Via PTEN/PI3K/AKT/P53 Pathway
Min Li1, Wei Li1, Feng-Qin Ren1
1Department of Intensive Care Unit, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong, 250013, China.
Aim:
The aim of this study is to explain the effects of miRNA-186 in renal injury induced by sepsis.
Methods:
The Wistar rats were divided into 3 groups: the Sham group, Sepsis model group and the miRNA-186 group based on the model group; there were 9 rats in every group. The rat sepsis model was reproduced by cecal ligation and puncture (CLP). The rats of the miRNA-186 group were injected miRNA-186 from caudal vein. The rats of the difference group were killed after operation 24 h. The kidneys of the difference groups were taken for histopathological and cell apoptosis analysis by H&E and TUNEL assay. The relative protein expressions were measured by WB assay. miRNA-186 target to Phosphatase and tensin homologous protein (PTEN).
Results:
Compared with the Sham group, the kidney histopathological and cell apoptosis rates of the model group were significantly damaged (P<0.05, respectively), however, the kidney histopathological and cell apoptosis rate of miRNA-186 group were significantly improved compared with the model group (P<0.05, respectively). The relative protein expressions were significantly different among 3 groups (P<0.05, respectively). The PTEN was the target of the miRNA-186.
Conclusion:
miRNA-186 over-expression has effects that improve renal injury induced by sepsis via PTEN pathway.
Insights
MicroRNA-186 (miRNA-186) protects against sepsis-induced kidney injury by targeting the PTEN pathway. This study demonstrates miRNA-186
Area of Science:
- Nephrology
- Molecular Biology
- Sepsis Research
Background:
- Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
- Renal injury is a common and severe complication of sepsis, leading to significant morbidity and mortality.
- MicroRNAs (miRNAs) play crucial roles in regulating cellular processes and have emerged as potential therapeutic targets in various diseases, including sepsis-induced kidney injury.
Purpose of the Study:
- To investigate the therapeutic effects of microRNA-186 (miRNA-186) on renal injury induced by sepsis.
- To elucidate the underlying molecular mechanisms, specifically focusing on the interaction between miRNA-186 and Phosphatase and tensin homologous protein (PTEN).
Main Methods:
- A sepsis model was established in Wistar rats using cecal ligation and puncture (CLP).
- Rats were divided into Sham, Sepsis, and miRNA-186 treatment groups.
- Kidney tissues were analyzed for histopathological changes and cell apoptosis using H&E and TUNEL assays, respectively.
- Protein expression levels were quantified using Western blot (WB) analysis.
Main Results:
- Sepsis induction led to significant renal histopathological damage and increased cell apoptosis compared to the Sham group (P<0.05).
- Administration of miRNA-186 significantly ameliorated kidney damage and reduced cell apoptosis in septic rats compared to the Sepsis group (P<0.05).
- Protein expression levels, including that of PTEN, were significantly altered among the groups, confirming PTEN as a target of miRNA-186.
Conclusions:
- Overexpression of miRNA-186 demonstrates a protective effect against sepsis-induced renal injury.
- The therapeutic benefits of miRNA-186 in sepsis-related kidney damage are mediated through the PTEN signaling pathway.
- miRNA-186 represents a potential therapeutic strategy for managing sepsis-induced kidney injury.
More Related Videos
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024